Purchase Order 75N93022P00528
Award Date 4/6/22
Potential Completion Date 9/30/24
Potential Value $703K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Piscataway, NJ 08854, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) awarded a $37,889.60 firm fixed-price purchase order contract to Genscript USA Inc., a biotechnology company in Piscataway, New Jersey, for custom gene synthesis and expression services. This requirement was sole-sourced to Genscript due to their specialized expertise in producing the specific gene constructs needed to support NIAID's vaccine research and development efforts. The contract...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $150,355.40 firm fixed price purchase order contract to Genscript USA Inc., a biotechnology company, for COVID-19 research services. The contract includes DNA synthesis, cloning, plasmid preparation, and antibody expression and purification to support the Vaccine Research Center's continued COVID-19 studies. The services are to be performed at the NIH facility...
- The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $727,162.50 firm fixed price purchase order to Genscript USA Inc. to support synthesis of SARS-CoV-2 variant genes in response to COVID-19. As the prime contractor, Genscript will perform the requested products and services from their location in Piscataway, New Jersey through August 2022. This contract leverages the NIH's expertise researching infectious...
- This firm fixed-price purchase order contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The $3,943.72 contract is for custom gene synthesis services to support NIAID's biomedical research programs. Genscript, a for-profit organization, has a strong track record of providing specialized molecular biology products and services to...
- This federal contract award was issued by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Genscript USA Inc., a for-profit biotechnology company based in Piscataway, New Jersey. The $20,092.74 firm fixed price contract is for custom gene synthesis services. The contract has no set-aside designation. Genscript specializes in gene synthesis, gene editing, and other molecular biology services, and has received...
- This federal contract award, valued at $5,091.65, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract is for gene synthesis services and does not have a set-aside designation. Genscript USA Inc. is a well-established provider of molecular biology products and services to various federal agencies, including the National...
- Genscript USA Incorporated will provide gene synthesis services to the National Institutes of Health's National Institute of Allergy and Infectious Diseases under a $12,500 firm fixed price purchase order. The one-year contract was awarded on September 14, 2023 and runs through September 13, 2024. Genscript will deliver the gene synthesis work from its location in Piscataway, New Jersey. No subcontractors or additional context were provided regarding the specific research being supported under...
- <p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Genscript USA Inc. for antibody gene synthesis and production, valued at $16,974.27, on August 26, 2020. The order was firm fixed price with an ultimate completion date of February 6, 2021. Work was performed at Genscript's facility in Piscataway, New Jersey.</p>
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The $21,095.60 contract is for the provision of custom gene synthesis services to support NIAID's biomedical research and public health initiatives. Genscript USA Inc. is an experienced federal contractor, having received numerous...
- This federal contract award to Genscript USA Inc., a biotechnology company based in New Jersey, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS). The $4,196.16 firm fixed-price purchase order is for gene synthesis services. Genscript, a for-profit organization, has a history of providing a wide range of molecular biology products and services to...